DAFNA Capital Management

Latest statistics and disclosures from DAFNA Capital Management's latest quarterly 13F-HR filing:

Tip: Access up to 7 years of quarterly data

Positions held by DAFNA Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for DAFNA Capital Management

DAFNA Capital Management holds 76 positions in its portfolio as reported in the December 2023 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Spdr S&p Biotech Etf Etf (XBI) 10.4 $43M -14% 484k 89.29
 View chart
Cytokinetics Com New (CYTK) 8.0 $33M -16% 400k 83.49
 View chart
Stereotaxis Com New (STXS) 5.7 $24M 14M 1.75
 View chart
Ideaya Biosciences (IDYA) 4.4 $18M +3% 516k 35.58
 View chart
Syndax Pharmaceuticals (SNDX) 3.8 $16M +62% 743k 21.61
 View chart
Ascendis Pharma A/s Sponsored Adr (ASND) 3.7 $16M -9% 124k 125.95
 View chart
Karuna Therapeutics Ord (KRTX) 3.7 $15M -8% 48k 316.51
 View chart
Revolution Medicines (RVMD) 3.5 $15M +8% 512k 28.68
 View chart
Ishares Nasdaq Biotech Indx Etf (IBB) 3.3 $14M 103k 135.85
 View chart
Xenon Pharmaceuticals (XENE) 3.1 $13M 277k 46.06
 View chart
Merus N V (MRUS) 3.0 $13M -6% 455k 27.50
 View chart
Blueprint Medicines (BPMC) 2.5 $10M -55% 111k 92.24
 View chart
Day One Biopharmaceuticals I (DAWN) 2.4 $10M +17% 687k 14.60
 View chart
Neurocrine Biosciences (NBIX) 2.3 $9.6M 73k 131.76
 View chart
Dex (DXCM) 2.0 $8.4M 68k 124.09
 View chart
Kalvista Pharmaceuticals (KALV) 1.8 $7.4M 601k 12.25
 View chart
Biohaven (BHVN) 1.7 $7.2M +382% 169k 42.80
 View chart
Kura Oncology (KURA) 1.7 $7.1M -10% 493k 14.38
 View chart
Morphic Hldg (MORF) 1.6 $6.7M 232k 28.88
 View chart
Tandem Diabetes Care Com New (TNDM) 1.6 $6.5M 221k 29.58
 View chart
Axogen (AXGN) 1.5 $6.4M 936k 6.83
 View chart
2seventy Bio Common Stock (TSVT) 1.5 $6.2M 1.4M 4.27
 View chart
ImmunoGen (IMGN) 1.4 $5.7M +133% 194k 29.65
 View chart
Sage Therapeutics (SAGE) 1.3 $5.3M NEW 245k 21.67
 View chart
Galapagos Nv Spon Adr (GLPG) 1.3 $5.3M +116% 130k 40.65
 View chart
Mirati Therapeutics (MRTX) 1.3 $5.3M -3% 89k 58.75
 View chart
Edgewise Therapeutics (EWTX) 1.2 $4.9M -13% 449k 10.94
 View chart
Alector (ALEC) 1.2 $4.9M -3% 610k 7.98
 View chart
Viking Therapeutics (VKTX) 1.1 $4.6M -22% 248k 18.61
 View chart
AtriCure (ATRC) 1.1 $4.5M 126k 35.69
 View chart
Arcus Biosciences Incorporated (RCUS) 1.1 $4.4M +4% 233k 19.10
 View chart
Century Therapeutics (IPSC) 1.0 $4.3M 1.3M 3.32
 View chart
BioCryst Pharmaceuticals (BCRX) 1.0 $4.2M +8% 710k 5.99
 View chart
Ascendis Pharma A/s Note 2.250% 4/0 (Principal) 1.0 $4.1M 4.0M 1.03
 View chart
Accuray Incorporated (ARAY) 0.8 $3.5M 1.2M 2.83
 View chart
Astria Therapeutics (ATXS) 0.8 $3.4M +51% 449k 7.68
 View chart
Keros Therapeutics (KROS) 0.7 $3.0M +12% 74k 39.76
 View chart
Acelyrin (SLRN) 0.7 $2.8M +4984% 371k 7.46
 View chart
Procept Biorobotics Corp (PRCT) 0.6 $2.7M -5% 63k 41.91
 View chart
Mediwound Shs New (MDWD) 0.6 $2.6M 258k 10.17
 View chart
Bicycle Therapeutics Sponsored Ads (BCYC) 0.5 $2.2M 122k 18.08
 View chart
Brainsway Sponsored Ads (BWAY) 0.5 $2.0M -28% 309k 6.48
 View chart
Proqr Therapeutics N V Shs Euro (PRQR) 0.4 $1.9M 941k 1.98
 View chart
Amylyx Pharmaceuticals (AMLX) 0.4 $1.8M 123k 14.72
 View chart
Mereo Biopharma Group Spon Ads (MREO) 0.4 $1.8M -19% 779k 2.31
 View chart
Immunovant (IMVT) 0.4 $1.7M +81% 41k 42.13
 View chart
Silverback Therapeutics (SPRY) 0.4 $1.7M NEW 311k 5.48
 View chart
Compass Pathways Sponsored Ads (CMPS) 0.4 $1.7M 193k 8.75
 View chart
Syros Pharmaceuticals Com New (SYRS) 0.4 $1.7M -19% 215k 7.79
 View chart
Spruce Biosciences (SPRB) 0.4 $1.6M -3% 549k 2.93
 View chart
Larimar Therapeutics (LRMR) 0.4 $1.5M 324k 4.55
 View chart
Macrogenics (MGNX) 0.4 $1.5M -41% 152k 9.62
 View chart
Regulus Therapeutics (RGLS) 0.3 $1.4M 1.1M 1.28
 View chart
Argen Se Sponsored Adr (ARGX) 0.3 $1.4M NEW 3.6k 380.43
 View chart
Gossamer Bio (GOSS) 0.3 $1.3M 1.5M 0.91
 View chart
Cullinan Oncology (CGEM) 0.3 $1.3M 127k 10.19
 View chart
Autolus Therapeutics Spon Ads (AUTL) 0.3 $1.2M -79% 191k 6.44
 View chart
Sutro Biopharma (STRO) 0.3 $1.2M 283k 4.29
 View chart
Immatics Nv SHS (IMTX) 0.3 $1.1M NEW 105k 10.53
 View chart
Iteos Therapeutics (ITOS) 0.3 $1.1M 99k 10.95
 View chart
Neuronetics (STIM) 0.2 $910k 314k 2.90
 View chart
Oric Pharmaceuticals (ORIC) 0.2 $670k NEW 73k 9.20
 View chart
Acrivon Therapeutics Common Stock (ACRV) 0.2 $646k +70% 131k 4.92
 View chart
Nevro (NVRO) 0.1 $603k 28k 21.52
 View chart
Compugen Ord (CGEN) 0.1 $406k 205k 1.98
 View chart
Masimo Corporation (MASI) 0.1 $352k 3.0k 117.21
 View chart
Adaptimmune Therapeutics Sponds Adr (ADAP) 0.1 $278k 351k 0.79
 View chart
Vigil Neuroscience (VIGL) 0.1 $243k -58% 72k 3.38
 View chart
Elevation Oncology (ELEV) 0.1 $242k 450k 0.54
 View chart
Vistagen Therapeutics Ord (VTGN) 0.1 $215k NEW 42k 5.14
 View chart
Spero Therapeutics (SPRO) 0.0 $184k 125k 1.47
 View chart
Compass Therapeutics (CMPX) 0.0 $182k 117k 1.56
 View chart
Karyopharm Therapeutics (KPTI) 0.0 $167k 193k 0.86
 View chart
Mineralys Therapeutics (MLYS) 0.0 $131k NEW 15k 8.60
 View chart
Kinnate Biopharma (KNTE) 0.0 $119k -52% 50k 2.37
 View chart
Inogen (INGN) 0.0 $82k 15k 5.49
 View chart

Past Filings by DAFNA Capital Management

SEC 13F filings are viewable for DAFNA Capital Management going back to 2010

View all past filings